| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |